CALGB 140503 - A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (d 2 CM) Peripheral Non-Small Cell Lung Cancer
CALGB 30504 - Combination Cisplatin, Etoposide and Sunitinib for Untreated Extensive Stage Small Cell Lung Cancer: A Phase IB/II Study
CALGB 30602 - A Phase Ii Study of Dasatinib (NSC #732517, IND #73969) In Patients with Chemo-Sensitive Relapsed Small Cell Lung Cancer
CALGB 30605 - A Phase II Study of Induction Chemotherapy Followed By Thoracic Radiotherapy and Erlotinib In Poor-Risk Stage III Non-Small Cell Lung Cancer
CALGB 30607 - Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer
CALGB 30610 - Phase III Comparison of Thoracic Radiotherapy Regimens In Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
CALGB 30801 - A Randomized Phase III Double-blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced NSCLC
GCC 0532 - Phase 1-2a Dose-Ranging Study of the Triplet Combination of Carboplatin, Paclitaxel and TLK286 as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
GCC 0616 - Phase 2 Study of AZD 2171 (NSC 732208) in Combination with Pemetrexed in Relapsed Non-Small Cell Lung Cancer (NOS:10029514
GCC 0757 - (ECOG 1505) A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (4 cm or larger) - IIIA Non-Small Cell Lung Cancer (NSCLC)
GCC 0793 - A Multicenter Phase III Randomized, Double-Blind Placebo-Controlled Study of the Cancer Vaccine Stimuvax® (L-BLP25 or BLP25 Liposome Vaccine) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease
GCC 0822 - A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination with either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
GCC 0926 - PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF EFFICACY AND SAFETY OF PF-02341066 VS STANDARD OF CARE CHEMOTHERAPY(Pemetrexed Or Docetaxel) In Patients With Advanced Nonsmall Cell Lung Cancer (Nsclc) Harboring A Translocation Or Inversion Event Involving The Anaplastic Lymphoma Kinase
H-30449 / RTOG 0618 - A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of
Email this Page
Print this Page
